TheEdgeResearch
Home / Stocks / CRCC.CN

Copland Road Capital Corporation (CRCC.CN)

CNQ Healthcare Drug Manufacturers - Specialty & Generic
$0.13 ▲ +0.00%
Market Cap
$1.4M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.27
52-Wk Range
0.125-0.195
CEO
Bruce Langstaff
Country
CA
Currency
CAD

Copland Road Capital Corporation operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.13, up 0.00% on the session, giving a market capitalisation of $1.4M. Its beta of 0.27 implies it has historically moved less than the broad market.

Company profile
Exchange
Canadian Securities Exchange
Employees
54
IPO date
2002-06-19
Headquarters
Toronto, ON, CA
About Copland Road Capital Corporation

Operating as a principal investment firm, Copland Road Capital Corporation, previously known as Nabis Holdings Inc., dedicates its capital deployment to the cannabis industry. The company primarily targets investment opportunities within the United States. Its strategy involves acquiring controlling (majority) stakes in the businesses it finances and often prefers that selling entities accept a significant part of their payment in the form of company equity. Established in 2002, Copland Road Capital Corporation is headquartered in Vancouver, Canada, and also maintains an office in Toronto.

Comparable companies

Copland Road Capital Corporation is most often compared with the following Healthcare names:

CPTR.CNMOOD.CNOVAT.CNPBF.CNPHA.VPHRX.CNPSYG.CNRAMM.CNVENI.CNXTRX.CN
More research on CRCC.CN
CRCC.CN technical analysis CRCC.CN TheEdge Score Compare against peers
Open full interactive analysis & DCF →